دورية أكاديمية

Does FFAR4 agonism have therapeutic potential in cardiometabolic disease?

التفاصيل البيبلوغرافية
العنوان: Does FFAR4 agonism have therapeutic potential in cardiometabolic disease?
المؤلفون: Lay, Abigail C
المصدر: Lay , A C 2021 , ' Does FFAR4 agonism have therapeutic potential in cardiometabolic disease? ' , Endocrinology , vol. 162 , no. 10 , bqab145 . https://doi.org/10.1210/endocr/bqab145Test
سنة النشر: 2021
المجموعة: University of Bristol: Bristol Reserach
مصطلحات موضوعية: FFAR4, GPR120, diabetes, obesity, metabolic syndrome, cardiometabolic disease, vascular disease, atherosclerosis, CVD
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
DOI: 10.1210/endocr/bqab145
الإتاحة: https://doi.org/10.1210/endocr/bqab145Test
https://hdl.handle.net/1983/6fbf365d-408a-4df6-ba81-73c5780c7834Test
https://research-information.bris.ac.uk/en/publications/6fbf365d-408a-4df6-ba81-73c5780c7834Test
https://research-information.bris.ac.uk/ws/files/282875022/ACCEPTED_bqab145.pdfTest
https://research-information.bris.ac.uk/ws/files/288732024/Full_text_PDF_final_published_version_.pdfTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.805C75B3
قاعدة البيانات: BASE